Differences in collagen structure and organization in primary and metastatic pancreatic cancer and the effects of FOLFIRINOX treatment.
Source: PubMed, NCBI / U.S. National Library of Medicine
Pancreatic ductal adenocarcinoma (PDAC) is defined by a dense, collagen-rich stroma that limits therapeutic efficacy and drives metastasis. While collagen reorganization has been studied in resected PDAC tumors, its structure and organization in metastatic PDAC and response to chemotherapy remains poorly characterized. We evaluated collagen structure by Second Harmonic Generation (SHG) imaging of formalin fixed paraffin embedded tissue from pancreatic tumors and liver metastases of 20 PDAC patients that were untreated or treated with FOLFOX or FOLFIRINOX (FOL). Collagen fiber width, length, alignment, and density were assessed at tumor cores, tumor boundaries, and in the adjacent tissue. We document for the first time fundamental differences in these collagen structure features between normal pancreas and normal liver. Surprisingly, the structure of collagen in primary pancreatic cancer was similar to normal pancreas. Liver metastases showed alterations in collagen structure, revealing a transition from a liver-like collagen phenotype (thinner, shorter less dense collagen fibers) at the tumor border to a tumor-core phenotype with thicker, longer, less aligned, and denser collagen fibers. FOL treatment increased length, width, and density at both primary tumors and liver metastases. Overall, these findings reveal organ specific collagen remodeling in PDAC and suggest that chemotherapy with FOL modulates extracellular matrix (ECM) remodeling. These findings expand the scope of
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is defined by a dense, collagen-rich stroma that limits therapeutic efficacy and drives metastasis. While collagen reorganization has been studied in resected PDAC tumors, its structure and organization in metastatic PDAC and response to chemotherapy remains poorly characterized. We evaluated collagen structure by Second Harmonic Generation (SHG) imaging of formalin fixed paraffin embedded tissue from pancreatic tumors and liver metastases of 20 PDAC patients that were untreated or treated with FOLFOX or FOLFIRINOX (FOL). Collagen fiber width, length, alignment, and density were assessed at tumor cores, tumor boundaries, and in the adjacent tissue. We document for the first time fundamental differences in these collagen structure features between normal pancreas and normal liver. Surprisingly, the structure of collagen in primary pancreatic cancer was similar to normal pancreas. Liver metastases showed alterations in collagen structure, revealing a transition from a liver-like collagen phenotype (thinner, shorter less dense collagen fibers) at the tumor border to a tumor-core phenotype with thicker, longer, less aligned, and denser collagen fibers. FOL treatment increased length, width, and density at both primary tumors and liver metastases. Overall, these findings reveal organ specific collagen remodeling in PDAC and suggest that chemotherapy with FOL modulates extracellular matrix (ECM) remodeling. These findings expand the scope of PDAC collagen structural characterization and highlight the complexity of matrix targeting strategies in metastatic disease.